Journal of Agricultural and Food Chemistry · 2021 · 30 citations · 35 references
PharmacyBiochemistryPharmacologyDrug DiscoveryMolecular PharmacologyStructure-activity RelationshipsAntiviral PharmacologyEnzyme InhibitionMolecular DockingMolecular Docking InformaticsStructure-activity Relationship AnalysisTannin ChemistryCondensed TanninsHydrolysable TanninsHydrolyzable TanninsMicrobial MetabolitesSars-cov-2 InfectionTannin BindingTannin-protein BindingTannin-protein Interactions
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) main protease (Mpro) inhibitors are considered as potential treatments for coronavirus disease 2019, and dietary polyphenols show promise in SARS-CoV-2 Mpro inhibition based on in silico studies. In the present study, we utilize a combination of biochemical-, surface plasmon resonance-, and docking-based assays to evaluate the inhibition and binding affinities of a series of tannins and their gut microbial metabolites on SARS-CoV-2 Mpro. The tested compounds (2–50 μM) were hydrolyzable tannins, including ellagitannins (punicalagin and ellagic acid) and gallotannins (tannic acid, pentagalloyl glucose, ginnalin A, and gallic acid), and their gut microbial metabolites, urolithins and pyrogallol, respectively. They inhibited SARS-CoV-2 Mpro (by 6.6–100.0% at 50 μM) and bound directly to the Mpro protein (with dissociation constants from 1.1 × 10–6 to 5.3 × 10–5 M). This study sheds light on the inhibitory effects of tannins and their metabolites on SARS-CoV-2 Mpro.
35
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin, Xiaoyu Du, Yechun Xu et al. · Nature · 2020 · 4.5K citations · Full text
Juan Carlos Espı́n, Mar Larrosa, María‐Teresa García‐Conesa et al. · Evidence-based Complementary and Alternative Medicine · 2013 · 559 citations · Full text
SARS-CoV-2 M <sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse model
Jingxin Qiao, Yueshan Li, Rui Zeng et al. · Science · 2021 · 450 citations · Full text